SCD News Hub

Discover a diverse range of news stories, encompassing awareness campaigns, research advancements, upcoming events, reproductive health discussions, mental health support initiatives, and so much more. We scour reputable sources worldwide, ensuring you receive the most accurate and relevant information available.
  • Newborn sickle cell screening still a challenge, says ICMR: Tribals battle fear, stigma and long journeys

    Article Image

    A study by ICMR finds that poor awareness, discrimination and healthcare access gaps continue to delay diagnosis and treatment for children with sickle cell disease.

    Read more
  • Sickle Cell Disease hospitalizations in Louisiana parishes

    Article Image

    Discover the latest data on sickle cell disease hospitalizations in Louisiana, including statistics by parish and efforts to improve healthcare access.

    Read more
  • Oakland hospital receives $1 million for blood disorder research center

    Article Image

    UCSF Benioff Children's Hospital Oakland will receive $1.03 million in federal funding to establish a pediatric blood disorder research center focused on sickle cell disease, thalassemia, leukemia and other conditions.

    Read more
  • US stocks: Fulcrum shares plummet over 50% after scrapping lead sickle-cell drug on FDA concerns

    Article Image

    The oral drug, pociredir, was ‌being tested ⁠to treat sickle-cell ⁠disease, an inherited blood disorder that can trigger pain, anemia and organ damage and ​reduce life expectancy.

    Read more
  • Stem cell transplantation found to be more cost-effective than gene therapy for sickle cell disease

    Article Image

    Stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults when compared with gene therapy and standard of care treatment, according to new research published in Blood .

    Read more
  • Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns

    Article Image

    Shares of Fulcrum Therapeutics plunged 52% on Tuesday after the company said it would abandon development of its experimental sickle-cell disease drug following cancer-risk concerns raised by the U.S....

    Read more
  • Fulcrum plummets 50% after scrapping lead sickle-cell drug on FDA concerns

    Article Image

    Shares of Fulcrum Therapeutics plunged 50% in premarket trading on Tuesday after the company said it would abandon development of its experimental sickle-cell disease drug following cancer-risk ​concerns raised by the U.S. FDA, and explore strategic options ‌including a potential sale or merger.

    Read more
  • FULC Stock Crashes After Hours: What Investors Need To Know

    Article Image

    Fulcrum Therapeutics stock plunged after the company discontinued its lead sickle cell disease drug following FDA concerns.

    Read more
  • High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease

    Article Image

    **media[1081345]**CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206

    Read more
  • High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease

    Article Image

    /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE)...

    Read more

Get Involved Today

Breaking Barriers, Building Hope for Sickle Cell Warriors